Anas Younes is leading an effort to find new lymphoma biomarkers.
Ross Levine has led research into a new diagnostic test for blood cancers.
Sergio Giralt studies treatments tailored to older leukemia patients.
The Division of Hematologic Malignancies within Memorial Sloan Kettering’s Department of Medicine consists of five services: Adult Bone Marrow Transplantation, Hematology, Leukemia, Lymphoma, and Myeloma. As nationally and internationally recognized leaders in their fields, members of our team are central players in advancing clinical research and establishing the standard of care for patients with hematologic cancers.
Our division is dedicated to treating patients with a variety of blood cancers as well as some benign hematologic diseases. We also oversee bone marrow and stem cell transplants — both autologous and allogeneic — in more than 450 patients each year. Close collaboration between our physicians and scientists allows us to provide patients with top-quality clinical care while we develop groundbreaking therapies to prevent, control, and ultimately cure cancer.